· Weekly signal · GH

Guardant Health Inc (GH) carries a 38.7% four-week climb into weekly view

The precision-oncology testing stock remains in an active weekly trend, but volume and relative-strength readings keep the confirmation from looking one-sided.

Precision oncology diagnostics lab with blood samples and market data screen representing Guardant Health.

Guardant Health Inc (GH) finished the latest week at 131.62 USD, up 4.8%, with the healthcare diagnostics name extending a broader advance in weekly market data.

The move is backed by an active trend signal and Market Dynamics confirmation at 1.11. The evidence is not uniformly strong: latest weekly volume of 9.28 million shares was below the 13-week average of 10.55 million, while Relative Strength stood at 32.6.

The chart shows the weekly price path over 52 weeks, so the setup reflects medium-term context rather than live intraday action.